Related references
Note: Only part of the references are listed.Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage breast cancer: A pharmacoepidemiologic study
V. Dezentje et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer
E. L. Mayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Hyman B. Muss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
C. McCowan et al.
BRITISH JOURNAL OF CANCER (2008)
Use of Electronic Monitoring in Clinical Nursing Research
Rita L. Ailinger et al.
Clinical Nursing Research (2008)
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
Cynthia Owusu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
AH Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer
RA Silliman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A systematic review of the associations between dose regimens and medication compliance
AJ Claxton et al.
CLINICAL THERAPEUTICS (2001)
Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
S Demissie et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
